Itzykson, Raphael <br/><br/>
Azacitidine for the treatment of relapsed and refractory AML in older patients.  [electronic resource] 

 -  Leukemia research  Feb 2015 
 - 124-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2014.11.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Azacitidine--administration & dosage<br/>Blast Crisis--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Retrospective Studies<br/>Risk Factors<br/>Survival Rate